Statement of Consent to Prepare Abridged Financial Statements
|
|
All of the members of James Shand Heart Health Limited have consented to the preparation of the abridged income statement and the abridged statement of financial position for the year ending 31 August 2017 in accordance with Section 444(2A) of the Companies Act 2006.
COMPANY REGISTRATION NUMBER:
NI633132
James Shand Heart Health Limited
|
|
Filleted Unaudited Abridged Financial Statements
|
|
James Shand Heart Health Limited
|
|
Abridged Financial Statements
|
|
Year ended 31 August 2017
Abridged statement of financial position
|
1
|
|
|
Notes to the abridged financial statements
|
2
|
|
|
James Shand Heart Health Limited
|
|
Abridged Statement of Financial Position
|
|
31 August 2017
Fixed assets
Tangible assets
|
4
|
5,497
|
5,464
|
|
|
|
|
Current assets
Debtors
|
–
|
3,260
|
Cash at bank and in hand
|
18,892
|
20,750
|
|
--------
|
--------
|
|
18,892
|
24,010
|
|
|
|
Creditors: amounts falling due within one year
|
8,709
|
17,374
|
|
--------
|
--------
|
Net current assets
|
10,183
|
6,636
|
|
--------
|
--------
|
Total assets less current liabilities
|
15,680
|
12,100
|
|
--------
|
--------
|
Net assets
|
15,680
|
12,100
|
|
--------
|
--------
|
|
|
|
Capital and reserves
Called up share capital
|
100
|
100
|
Profit and loss account
|
15,580
|
12,000
|
|
--------
|
--------
|
Members funds
|
15,680
|
12,100
|
|
--------
|
--------
|
|
|
|
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged income statement has not been delivered.
For the year ending 31 August 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
-
The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476
;
-
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements
.
These abridged financial statements were approved by the
board of directors
and authorised for issue on
4 January 2018
, and are signed on behalf of the board by:
Company registration number:
NI633132
James Shand Heart Health Limited
|
|
Notes to the Abridged Financial Statements
|
|
Year ended 31 August 2017
1.
General information
The company is a private company limited by shares, registered in Northern Ireland. The address of the registered office is 43 Clarendon Street, Derry, BT48 7ER, Northern Ireland.
2.
Statement of compliance
These abridged financial statements have been prepared in compliance with the provisions of FRS 102 Section 1A, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3.
Accounting policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Transition to FRS 102
The entity transitioned from previous UK GAAP to FRS 102 as at 1 September 2015. Details of how FRS 102 has affected the reported financial position and financial performance is given in note 5.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
|
Plant and machinery
|
-
|
20% straight line
|
|
Equipment
|
-
|
20% straight line
|
|
|
|
|
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities. Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability. Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.
4.
Tangible assets
|
£
|
Cost
|
|
At 1 September 2016
|
6,830
|
Additions
|
1,750
|
|
-------
|
At 31 August 2017
|
8,580
|
|
-------
|
Depreciation
|
|
At 1 September 2016
|
1,366
|
Charge for the year
|
1,717
|
|
-------
|
At 31 August 2017
|
3,083
|
|
-------
|
Carrying amount
|
|
At 31 August 2017
|
5,497
|
|
-------
|
At 31 August 2016
|
5,464
|
|
-------
|
|
|
5.
Transition to FRS 102
These are the first abridged financial statements that comply with FRS 102. The company transitioned to FRS 102 on 1 September 2015.
No transitional adjustments were required in equity or profit or loss for the period.